Literature DB >> 36105328

Application of Deuterated N,N-Dimethyltryptamine in the Potential Treatment of Psychiatric and Neurological Disorders.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2022        PMID： 36105328      PMCID： PMC9465894          DOI： 10.1021/acsmedchemlett.2c00354

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  The promises and perils of psychedelic pharmacology for psychiatry.

Authors:  Tristan D McClure-Begley; Bryan L Roth
Journal:  Nat Rev Drug Discov       Date:  2022-03-17       Impact factor: 84.694

Review 2.  N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.

Authors:  Edward James; Joachim Keppler; Thomas L Robertshaw; Ben Sessa
Journal:  Hum Psychopharmacol       Date:  2022-02-17       Impact factor: 2.130

Review 3.  Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).

Authors:  Lindsay P Cameron; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-07-23       Impact factor: 4.418

4.  Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.

Authors:  Lindsay P Cameron; Charlie J Benson; Brian C DeFelice; Oliver Fiehn; David E Olson
Journal:  ACS Chem Neurosci       Date:  2019-03-04       Impact factor: 4.418

Review 5.  Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.

Authors:  Nataliya Vorobyeva; Alena A Kozlova
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

Review 6.  Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT.

Authors:  Steven A Barker
Journal:  Psychopharmacology (Berl)       Date:  2022-01-22       Impact factor: 4.415
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.